Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2010
10/28/2010US20100273892 Formulations of tocotrienol quinones for the treatment of ophthalmic diseases
10/28/2010US20100273870 Compositions and methods for treating demodex infestations
10/28/2010US20100273864 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
10/28/2010US20100273854 Compositions and methods for inhibiting nadph oxidase expression
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273821 Methods and compositions for treating dry eye
10/28/2010US20100273813 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
10/28/2010US20100273784 Fused ring heterocycles as potassium channel modulators
10/28/2010US20100273767 Modulators of 5-ht receptors and methods of use thereof
10/28/2010US20100273751 Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/28/2010US20100273749 Method for Treating Dry-Eye Syndrome
10/28/2010US20100273734 Derivatives of Hyaluronic Acids
10/28/2010US20100273721 Compositions and methods for treating ophthalmic disorders
10/28/2010US20100273720 Protective Complement Proteins and Age-Related Macular Degeneration
10/28/2010US20100273265 for inducing differentiation into retinal photoreceptor cells; for preventing/treating/suppressing progression of retinal diseases; retinitis pigmentosa, senile macular degeneration, diabetic retinopathy, retinal detachment, glaucoma and retinal vessel occlusion
10/28/2010US20100272803 Repair and regeneration of ocular tissue using postpartum-derived cells
10/28/2010US20100272791 Composition having effect on treatment and prevention of dry eye syndrome
10/28/2010US20100272780 CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THEREOF
10/28/2010US20100272777 Ocular therapeutic agent delivery devices and methdos for making and using such devices
10/28/2010US20100272756 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
10/28/2010US20100272754 Botulinum toxin administration to treat various conditions
10/28/2010US20100272733 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
10/28/2010US20100272722 Therapeutic uses of inhibitors of RTP801
10/28/2010US20100272719 Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
10/28/2010US20100272702 Methods and compositions for treating neuropathies
10/28/2010US20100272688 Method of treating or retarding the development of blindness
10/27/2010EP2243837A1 Carotene synthase gene and uses therefor
10/27/2010EP2243779A1 Bicyclic heterocyclic derivative
10/27/2010EP2243778A1 Piperidine derivative
10/27/2010EP2242491A1 Novel use of 3,3'-diindolylmethane
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN1887290B Lincomycin hydrochloride composition and its prepn
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN1585640B N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
10/27/2010CN101874029A Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/27/2010CN101873852A Methods and compounds for treating retinol-related diseases
10/27/2010CN101870734A Fusogenic polypeptide for inhibiting neovascularization and coding gene and application thereof
10/27/2010CN101869674A Chinese medicinal composition for treating vertigo
10/27/2010CN101869659A Chinese medicinal composition for treating vertigo
10/27/2010CN101869640A Traditional Chinese medicine for treating myopia
10/27/2010CN101869631A Toxicant elimination medicament for eyes
10/27/2010CN101869564A Medicinal composition taking dextrotolperisone as active ingredient
10/27/2010CN101102773B Aminopyrazine analogs for treating glaucoma and other RHO kinase-mediated diseases
10/27/2010CN101031310B Ophthalmic composition containing xanthan gum and amino acid
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820640 administering mixture of allopurinol, ebselen and n-acetylcysteine
10/26/2010US7820193 Anticancer agents; prevent forming blood vessels; removal blockage
10/26/2010US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
10/26/2010CA2543650C A crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing thesame
10/21/2010WO2010120838A1 Treating blurred vision and other conditions of the eye with cyclosporin composition
10/21/2010WO2010120741A1 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
10/21/2010WO2010120719A1 Compositions and methods for the treatment of inflammation
10/21/2010WO2010120566A2 METHODS FOR TREATING IgE-MEDIATED DISORDER
10/21/2010WO2010120237A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010WO2010119990A1 Pharmaceutical compositions
10/21/2010WO2010119986A1 Method and composition for treating macular degeneration
10/21/2010WO2010119942A1 Levocabastine suspension type eye lotion
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010119700A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
10/21/2010WO2010074992A3 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
10/21/2010WO2010056985A3 Treatment of proteinopathies using a farnesyl transferase inhibitor
10/21/2010WO2009134711A8 Humanized anti-factor d antibodies and uses thereof
10/21/2010US20100267832 Method for treating macular degeneration
10/21/2010US20100267822 Aurones as estrogen receptor modulators and their use in sex hormone dependent diseases
10/21/2010US20100267811 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
10/21/2010US20100267800 N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses
10/21/2010US20100267793 Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267761 7-Azaindole Derivatives as Selective 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
10/21/2010US20100267751 Pharmaceutical compositions and methods of treating dry eye disorders
10/21/2010US20100267746 Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity
10/21/2010US20100267738 Novel amide and amidine derivatives and uses thereof
10/21/2010US20100267731 Use of transforming growth factor-b receptor inhibitors to suppress ocular scarring
10/21/2010US20100267713 4,4-disubstituted piperidines
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267701 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
10/21/2010US20100267696 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267668 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010US20100267665 Remedy for corneal diseases
10/21/2010US20100267664 Ophthalmic compositions containing polysaccharide-borate gelling system
10/21/2010US20100267647 Modulating photoreactivity in a cell
10/21/2010US20100267646 Trophic Factor for the Treatment of Retinal Degenerative Diseases
10/21/2010US20100267645 Methods and compositions for treating ocular disease
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100267615 Methods for treatment and/or prevention of a disease associated with vascular leak
10/21/2010US20100267140 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/21/2010US20100266710 Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions
10/21/2010US20100266664 Devices And Methods For Ophthalmic Drug Delivery
10/21/2010US20100266622 Prevention and treatment of ocular side effects with a cyclosporin
10/21/2010US20100266574 Oligoribonucleotides and Methods of Use Thereof for Treatment of Fibrotic Conditions and Other Diseases
10/21/2010DE69229688C5 Ophthalmische Zusammensetzungen, die Kombinationen von einem Carboanhydrase-Inhibitor und einem Beta-adrenergischen Antagonist enthalten Containing ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
10/21/2010CA2761064A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010CA2758587A1 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
10/21/2010CA2758586A1 Compositions and methods for the treatment of inflammation
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/21/2010CA2757762A1 Method and composition for treating macular degeneration
10/20/2010EP2241319A1 Combination of brimonidine and timolol for topical ophthalmic use
10/20/2010EP2240473A1 Substituted gamma lactams as therapeutic agents
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 531